Regulation News

Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.

J&J Shares Dip on Lupus Drug Fast Track, Investors Eye Legal Risks
Regulation James Calloway

J&J Shares Dip on Lupus Drug Fast Track, Investors Eye Legal Risks

Johnson & Johnson shares declined 0.7% to $245.07 Wednesday after the FDA granted Fast Track designation to its lupus drug candidate nipocalimab, lagging behind a strong market advance.

JNJ SPY MRK ABBV PFE XLV
T-Mobile Countersues Verizon in Escalating Ad War Over 'Bait-and-Switch' Claims
Regulation James Calloway

T-Mobile Countersues Verizon in Escalating Ad War Over 'Bait-and-Switch' Claims

T-Mobile has launched a countersuit against Verizon, accusing its rival of 'bait-and-switch' tactics in a recent advertising campaign. The move escalates a legal fight that began when Verizon sued T-Mobile in February over alleged savings exaggerations.

TMUS VZ T
Tesla's EU Emissions Pool Loses Key Carmakers for 2026
Regulation James Calloway

Tesla's EU Emissions Pool Loses Key Carmakers for 2026

Stellantis, Toyota, and Subaru have not joined Tesla's 2026 EU carbon-credit pool, filings show, a shift from 2025. Tesla's regulatory credit revenue declined 28% to $1.99 billion last year.

TSLA STLA TM
EU's 'Made in EU' Rules Threaten Ford's Supply Chain
Regulation James Calloway

EU's 'Made in EU' Rules Threaten Ford's Supply Chain

The European Commission has proposed strict 'Made in EU' rules linking subsidies to local content, potentially excluding Ford's key suppliers in Britain and Turkey. The plan faces significant opposition and requires approval.

F TM RHHBY SIEGY SAP HSBC BACHY LVMUY SSNLF AZN NVS XLE XLF XLV XLK FXI MCHI
FDA Issues Second Ozempic Ad Warning to Novo Nordisk in Escalating Scrutiny
Regulation James Calloway

FDA Issues Second Ozempic Ad Warning to Novo Nordisk in Escalating Scrutiny

The FDA has sent Novo Nordisk a second advertising violation notice in under a month, citing misleading claims for Ozempic. The agency simultaneously warned 30 telehealth companies about compounded GLP-1 drug promotions.

NVO LLY XLV
Lilly Shares Decline Ahead of Key FDA Obesity Pill Decision
Regulation James Calloway

Lilly Shares Decline Ahead of Key FDA Obesity Pill Decision

Eli Lilly shares declined for a second day as the market anticipates an FDA decision on its oral obesity treatment in April. The FDA also issued warnings to telehealth firms marketing compounded weight-loss drugs.

LLY
Maryland School District Retreats from Electric Bus Plan, Seeks 140 Diesel Units
Regulation James Calloway

Maryland School District Retreats from Electric Bus Plan, Seeks 140 Diesel Units

Montgomery County Public Schools is requesting bids for 140 diesel school buses, citing persistent charging and maintenance problems with its electric fleet. The district continues to operate 285 electric buses under a 2021 contract currently under legal appeal.

Netflix Exits WBD Talks Over Price, Paramount Deal Faces Regulatory Scrutiny
Regulation James Calloway

Netflix Exits WBD Talks Over Price, Paramount Deal Faces Regulatory Scrutiny

Netflix has withdrawn from acquisition discussions with Warner Bros. Discovery due to price disagreements, while Paramount's competing $31 per share offer faces regulatory examination from California authorities.

NFLX WBD
SSE Gains on UK Grid Settlement, Eyes Full-Year Results
Regulation James Calloway

SSE Gains on UK Grid Settlement, Eyes Full-Year Results

SSE's stock advanced after its SSEN Transmission business agreed to Ofgem's RIIO-T3 regulatory settlement. The company is progressing 11 major grid projects, with 75% of key consents secured.

SSEZF
SSE Gains on Ofgem Grid Settlement, Eyes Full-Year Results
Regulation James Calloway

SSE Gains on Ofgem Grid Settlement, Eyes Full-Year Results

SSE's stock advanced following its SSEN Transmission unit's acceptance of Ofgem's RIIO-T3 regulatory settlement. Investors now shift focus to the company's upcoming full-year financial results.

SSEZF
Wesfarmers Gains Amid ACCC Scrutiny of Bunnings-Uber Eats Pact
Regulation James Calloway

Wesfarmers Gains Amid ACCC Scrutiny of Bunnings-Uber Eats Pact

Wesfarmers Limited closed higher following a complaint filed with regulators over Bunnings' exclusive delivery partnership with Uber Eats. The company's dividend reinvestment plan pricing window is now open.

Wesfarmers Gains Amid ACCC Complaint Over Bunnings-Uber Eats Pact
Regulation James Calloway

Wesfarmers Gains Amid ACCC Complaint Over Bunnings-Uber Eats Pact

Wesfarmers shares closed higher despite volatility after Mitre 10 lodged a competition complaint over Bunnings' exclusive delivery partnership with Uber Eats. The dividend reinvestment plan pricing period is now active.